Ada’s innovative platform merges expert health knowledge with advanced AI technology to deliver outstanding service. Initially renowned for their consumer app, the world’s most popular and highly-rated symptom assessment tool, Ada has seamlessly transitioned to providing cutting-edge enterprise solutions for health systems, insurers, and the life sciences sector.

Our journey with Ada began at the end of 2020, introduced by our German Venture Partner, and Ada’s exceptional execution and strategic leadership expansions in 2021 confirmed their place as a leader in the global health tech arena, which led to our investment in Ada's Series B extension in 2022.

The US market has always been a priority for Ada, and Red River West has played a pivotal role in their expansion, contributing to make it the largest market for Ada. Red River West was particularly involved with the launch of Patient Finders, Ada's solution for pharmaceuticals company, launched in 2023 nationwide. This product, which at its core connects patients with timely treatment, underscores Ada’s ability to deliver integrated, end-to-end healthcare solutions.

Fun fact: Back in 2019, Ada was the first health app to be launched in Swahili, a language spoken by over 100 million people across East Africa in countries such as Tanzania, Kenya and Uganda.